Parkinson's Disease Trial, Recruiting (NCT07386015)

Parkinson's Disease Trial, Recruiting NCT07386015 Sponsor: Tianjin Huanhu Hospital Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07386015 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 30 and 85 years old
You experience freezing while walking, difficulty with your walking pattern, or problems with balance
You have been diagnosed with Parkinson's disease or a related condition, such as PSP, MSA, DLB, CBD, vascular parkinsonism, or idiopathic normal pressure hydrocephalus (confirm with trial site if unsure which category applies to you)
You are able to complete walking and balance tests, either on your own or with some help
You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

You have severe memory or thinking difficulties, indicated by a very low score on a standard memory test (confirm with trial site)
You have a serious mental health condition that would make it difficult to take part in the study
You have a serious heart, lung, bone, muscle, or other health condition that makes walking unsafe
You have had a stroke, broken bone, or other major medical event in the last 3 months
You are unlikely to be able to attend or complete follow-up appointments or procedures
You are not willing to have video recordings or voice/speech recordings taken as part of the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 30 June 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07386015

Sponsor: Tianjin Huanhu Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

More information: https://clinicaltrials.gov/study/NCT07386015

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 30 and 85 years old
You experience freezing while walking, difficulty with your walking pattern, or problems with balance
You have been diagnosed with Parkinson's disease or a related condition, such as PSP, MSA, DLB, CBD, vascular parkinsonism, or idiopathic normal pressure hydrocephalus (confirm with trial site if unsure which category applies to you)
You are able to complete walking and balance tests, either on your own or with some help
You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

You have severe memory or thinking difficulties, indicated by a very low score on a standard memory test (confirm with trial site)
You have a serious mental health condition that would make it difficult to take part in the study
You have a serious heart, lung, bone, muscle, or other health condition that makes walking unsafe
You have had a stroke, broken bone, or other major medical event in the last 3 months
You are unlikely to be able to attend or complete follow-up appointments or procedures
You are not willing to have video recordings or voice/speech recordings taken as part of the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 30 June 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Tianjin Huanhu Hospital

Registry

ClinicalTrials.gov

Start date

28 February 2026

Est. completion

31 December 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in Freezing of Gait Severity Measured by the New Freezing of Gait Questionnaire (NFOG-Q)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov